|1.||Miyata, Takeshi: 3 articles (01/2011 - 12/2003)|
|2.||Fukuda, Takeshi: 2 articles (01/2004 - 05/2003)|
|3.||Watanabe, Naoto: 2 articles (01/2004 - 05/2003)|
|4.||Furue, Masutaka: 1 article (01/2011)|
|5.||Nakanishi, Yoichi: 1 article (01/2011)|
|6.||Hamada, Naoki: 1 article (01/2011)|
|7.||Yoshimura, Takesumi: 1 article (01/2011)|
|8.||Tokunaga, Shoji: 1 article (01/2011)|
|9.||Shibata, Satoko: 1 article (01/2011)|
|10.||Mitoma, Chikage: 1 article (01/2011)|
01/01/2004 - "1. Bakumondo-to significantly improved the cough threshold value in 76% of patients with BA and in 82% with non-BA conditions. "
01/01/2004 - "The present study was conducted to investigate the effect of Bakumondo-to on cough sensitivity in patients with BA and non-asthmatic (non-BA) conditions. "
01/01/2004 - "3. While Bakumondo-to did not significantly reduce the sputum eosinophil count, its effectiveness in suppressing cough was greatest in patients whose sputum eosinophil count was > or = 2%. "
01/01/2004 - "[The effects of bakumondo-to (mai-men-dong-tang) on asthmatic and non-asthmatic patients with increased cough sensitivity]."
05/01/2003 - "Bakumondo-to significantly increased the cough threshold. "
05/01/2003 - "And Bakumondo-to was more effective in asthmatic subjects with severe airway inflammation. "
01/01/2011 - "The study on airway inflammation has shown that even a Kampo preparation, Bakumondo-to, has anti-inflammatory, anti-allergic, immunomodulatory, secretory-modulating and metabolic regulatory actions. "
02/01/2007 - "The study on airway inflammation has shown that even a Kampo preparation, Bakumondo-to, has anti-inflammatory, anti-allergic, immunomodulatory, secretory-modulating, and metabolic regulatory actions. "
05/01/2003 - "The aim of the present study was to investigate the effect of Bakumondo-to on the cough sensitivity and respiratory tract inflammation in asthmatic patients with increased cough sensitivity. "
12/01/1999 - "We demonstrated that Bakumondo-to can attenuate airway hyperresponsiveness induced by ozone without affecting airway inflammation, which suggests that Bakumondo-to may act on the subsequent mechanisms after the induction of inflammation, such as mediator release."
|3.||Asthma (Bronchial Asthma)
05/01/2003 - "In addition influences of intensity of respiratory tract inflammation, gender, type of asthma, and disease period on the effect of Bakumondo-to on the cough sensitivity were examined. "
06/01/1993 - "These results suggest that Saiboku-to and Bakumondo-to but not Orengedoku-to potentiate beta-adrenergic function in airway smooth muscle, which may reflect the efficacy of these drugs on airway hyperresponsiveness and asthma."
|4.||Interstitial Lung Diseases (Interstitial Lung Disease)
04/01/2001 - "[Effect of Bakumondo-to on increased sensitivity of the cough reflex in a Sjögren syndrome patient with interstitial lung disease]."
01/01/1996 - "Bakumondo-to may be a good antitussive agent for interstitial pneumonia associated with a dry cough that is resistant to other antitussives."
05/01/2003 - "Our results suggest that Bakumondo-to may be an effective therapeutic preparation for coughing in asthmatic patients with cough hypersensitivity."
01/01/2004 - "Our results suggest that Bakumondo-to is an effective therapeutic preparation for cough hypersensitivity accompanying chronic cough disease, especially in cases of severe allergic inflammation."
05/01/2003 - "[Effects of Bakumondo-to (Mai-Men-Dong-Tang) on cough sensitivity to capsaicin in asthmatic patients with cough hypersensitivity]."
|3.||oren gedoku to
|7.||Codeine (Codeine Phosphate)
|8.||Antitussive Agents (Antitussives)
|9.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|1.||Kampo Medicine (Kampo)